The prevalence of fatigue among patients with chronic obstructive pulmonary disease (COPD) worldwide is approximately 59%, according to systematic review and meta-analysis findings published in ...
OhtuvayreTM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42.3 million in 2024 More prescriptions filled through February 2025 than in Q4 2024 Over 4,600 unique prescribers wit ...
Verona Pharma will host an investment community webcast and conference call at 9:00 a.m. EST / 2:00 p.m. GMT on Thursday, ...
Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...
This is the latest innovative treatment to be offered by the NHS. In January, the NHS announced a deal to offer curative sickle cell gene therapy, Casgevy®, which is being made in the UK, and follows ...
Recent medical research reveals promising developments in the treatment of patients suffering ... Global health projections indicate that COPD will affect approximately 600 million individuals ...
Featuring thousands of salons, shops and clinics across every every part of the UK, it’s the easiest and ... now — it's easy to find the salon and treatment you're looking for (there's a ...
The survey, which questioned 1,000 adults, found that popular spots for rule-breaking include train stations, playgrounds, and parks. A surprising 17 per cent confessed to puffing away in shopping ...
Estimates for payrolled employees in the UK decreased by 14,000 (0.0%) between November and December 2024 but rose by 44,000 (0.1%) between December 2023 and December 2024. Payrolled employees fell by ...
The estimated number of vacancies was 819,000 in the UK in November 2024 to January 2025; this is a decrease of 9,000, or 1.1%, from August to October 2024. Vacancy numbers decreased on the quarter ...
A hidden-away Somerset craft cider maker is making a name for itself across the UK with a £35,000 cash injection to help it grow. The money has been invested in new equipment meaning Pulpt can ...
“This could influence treatment decisions and improve respiratory health in this high-risk population.” “GLP-1 medications might help lower COPD exacerbation risk by reducing systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results